[{"address1": "126 East Lincoln Avenue", "city": "Rahway", "state": "NJ", "zip": "07065", "country": "United States", "phone": "908 740 4000", "website": "https://www.merck.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.", "fullTimeEmployees": 73000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert M. Davis J.D.", "age": 57, "title": "Chairman, President & CEO", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 4946636, "exercisedValue": 12137946, "unexercisedValue": 8920883}, {"maxAge": 1, "name": "Ms. Caroline A. Litchfield", "age": 55, "title": "Executive VP & CFO", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 2647054, "exercisedValue": 2581579, "unexercisedValue": 7022207}, {"maxAge": 1, "name": "Ms. Betty D. Larson", "age": 48, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 2294965, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard R. DeLuca Jr.", "age": 61, "title": "Executive VP & President of Merck Animal Health", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 2169938, "exercisedValue": 0, "unexercisedValue": 5823540}, {"maxAge": 1, "name": "Dr. Dean Y. Li M.D., Ph.D.", "age": 61, "title": "Executive VP & President of Merck Research Laboratories", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 3281100, "exercisedValue": 932530, "unexercisedValue": 4699987}, {"maxAge": 1, "name": "Mr. Dalton E. Smart III", "age": 57, "title": "Senior VP of Finance, Principal Accounting Officer & Global Controller", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Michael Williams", "age": 55, "title": "Executive VP and Chief Information & Digital Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Dannenbaum", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer L. Zachary J.D.", "age": 46, "title": "Executive VP & General Counsel", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 2732334, "exercisedValue": 3461623, "unexercisedValue": 4142191}, {"maxAge": 1, "name": "Ms. Cristal N. Downing", "age": 55, "title": "Executive VP and Chief Communications & Public Affairs Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 4, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.merck.com/investors/home.html", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 81.53, "open": 81.805, "dayLow": 81.01, "dayHigh": 82.4, "regularMarketPreviousClose": 81.53, "regularMarketOpen": 81.805, "regularMarketDayLow": 81.01, "regularMarketDayHigh": 82.4, "dividendRate": 3.24, "dividendYield": 3.97, "exDividendDate": 1757894400, "payoutRatio": 0.49310002, "fiveYearAvgDividendYield": 3.02, "beta": 0.379, "trailingPE": 12.559322, "forwardPE": 8.671277, "volume": 10875046, "regularMarketVolume": 10875046, "averageVolume": 13273458, "averageVolume10days": 12455730, "averageDailyVolume10Day": 12455730, "bid": 81.41, "ask": 82.37, "bidSize": 4, "askSize": 2, "marketCap": 203594317824, "fiftyTwoWeekLow": 73.31, "fiftyTwoWeekHigh": 118.16, "priceToSalesTrailing12Months": 3.2003634, "fiftyDayAverage": 82.751, "twoHundredDayAverage": 86.76725, "trailingAnnualDividendRate": 3.16, "trailingAnnualDividendYield": 0.03875874, "currency": "USD", "tradeable": false, "enterpriseValue": 230441304064, "profitMargins": 0.25789, "floatShares": 2493836714, "sharesOutstanding": 2497783211, "sharesShort": 23829923, "sharesShortPriorMonth": 25879122, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.0095, "heldPercentInsiders": 0.00067000004, "heldPercentInstitutions": 0.80597997, "shortRatio": 1.96, "shortPercentOfFloat": 0.0106, "impliedSharesOutstanding": 2497783211, "bookValue": 19.573, "priceToBook": 4.16441, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "earningsQuarterlyGrowth": -0.188, "netIncomeToCommon": 16405999616, "trailingEps": 6.49, "forwardEps": 9.4, "lastSplitFactor": "1048:1000", "lastSplitDate": 1622678400, "enterpriseToRevenue": 3.622, "enterpriseToEbitda": 8.134, "52WeekChange": -0.2950791, "SandP52WeekChange": 0.1653893, "lastDividendValue": 0.81, "lastDividendDate": 1757894400, "quoteType": "EQUITY", "currentPrice": 81.51, "targetHighPrice": 141.0, "targetLowPrice": 82.0, "targetMeanPrice": 102.125, "targetMedianPrice": 99.0, "recommendationMean": 2.03704, "recommendationKey": "buy", "numberOfAnalystOpinions": 24, "totalCash": 8622000128, "totalCashPerShare": 3.452, "ebitda": 28330000384, "totalDebt": 35401998336, "quickRatio": 0.82, "currentRatio": 1.424, "totalRevenue": 63616000000, "debtToEquity": 72.161, "revenuePerShare": 25.214, "returnOnAssets": 0.13007, "returnOnEquity": 0.35421002, "grossProfits": 49245999104, "freeCashflow": 15555000320, "operatingCashflow": 18534000640, "earningsGrowth": -0.178, "revenueGrowth": -0.019, "grossMargins": 0.77411, "ebitdaMargins": 0.44533002, "operatingMargins": 0.37473, "financialCurrency": "USD", "symbol": "MRK", "language": "en-US", "region": "US", "typeDisp": "Equity", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": 6.49, "epsForward": 9.4, "epsCurrentYear": 8.92618, "priceEpsCurrentYear": 9.131566, "fiftyDayAverageChange": -1.2409973, "fiftyDayAverageChangePercent": -0.014996765, "twoHundredDayAverageChange": -5.257248, "twoHundredDayAverageChangePercent": -0.060590234, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": -252322200000, "postMarketChangePercent": 0.1472152, "postMarketPrice": 81.63, "postMarketChange": 0.11999512, "regularMarketChange": -0.0199966, "regularMarketDayRange": "81.01 - 82.4", "averageDailyVolume3Month": 13273458, "fiftyTwoWeekLowChange": 8.200005, "fiftyTwoWeekLowChangePercent": 0.11185384, "fiftyTwoWeekRange": "73.31 - 118.16", "fiftyTwoWeekHighChange": -36.65, "fiftyTwoWeekHighChangePercent": -0.31017265, "fiftyTwoWeekChangePercent": -29.507912, "dividendDate": 1759795200, "earningsTimestamp": 1761827400, "earningsTimestampStart": 1761827400, "earningsTimestampEnd": 1761827400, "earningsCallTimestampStart": 1761829200, "earningsCallTimestampEnd": 1761829200, "isEarningsDateEstimate": false, "fullExchangeName": "NYSE", "shortName": "Merck & Company, Inc.", "longName": "Merck & Co., Inc.", "corporateActions": [], "postMarketTime": 1758326399, "regularMarketTime": 1758312095, "exchange": "NYQ", "messageBoardId": "finmb_288502", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.0245267, "regularMarketPrice": 81.51, "marketState": "CLOSED", "displayName": "Merck &", "trailingPegRatio": 0.7296, "__fetch_time": "2025-09-20"}]